tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

ASND Stock Latest News

Ascendis Pharma Closes Warrant Exercise Window, Boosts Share Capital
Company AnnouncementsAscendis Pharma Closes Warrant Exercise Window, Boosts Share Capital
14h ago
6K
ASND
VISEN Pharmaceuticals Prices IPO on Hong Kong Stock Exchange
PremiumCompany Announcements
VISEN Pharmaceuticals Prices IPO on Hong Kong Stock Exchange
9d ago
6K
ASND
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
9d ago
PLX
SLS
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
10d ago
PLX
ANNX
Ascendis Pharma’s Yorvipath Gains Edge in Hypoparathyroidism Market Amid AstraZeneca’s Uncertain Trial Results
PremiumRatings
Ascendis Pharma’s Yorvipath Gains Edge in Hypoparathyroidism Market Amid AstraZeneca’s Uncertain Trial Results
10d ago
ASND
Ascendis Pharma price target raised to $200 from $168 at JPMorgan
PremiumThe FlyAscendis Pharma price target raised to $200 from $168 at JPMorgan
11d ago
ASND
Bullish Outlook for Ascendis Pharma’s Yorvipath Amid Competitive Edge in Hypoparathyroidism Market
Premium
Ratings
Bullish Outlook for Ascendis Pharma’s Yorvipath Amid Competitive Edge in Hypoparathyroidism Market
11d ago
ASND
Ascendis Pharma’s Market Strength and Positive Trial Outcomes Drive Buy Rating
Premium
Ratings
Ascendis Pharma’s Market Strength and Positive Trial Outcomes Drive Buy Rating
12d ago
ASND
Ascendis Pharma Grants Employee Warrants to Strengthen Retention
PremiumCompany Announcements
Ascendis Pharma Grants Employee Warrants to Strengthen Retention
17d ago
6K
ASND
Ascendis Pharma’s Promising Outlook: Buy Rating Backed by Yorvipath Launch and TransCon CNP Potential
PremiumRatings
Ascendis Pharma’s Promising Outlook: Buy Rating Backed by Yorvipath Launch and TransCon CNP Potential
22d ago
ASND
Optimistic Buy Rating for Ascendis Pharma Amid Competitive Landscape in HypoPTH Market
PremiumRatings
Optimistic Buy Rating for Ascendis Pharma Amid Competitive Landscape in HypoPTH Market
23d ago
ASND
Specialised Therapeutics announces TGA approval of YORVIPATH
PremiumThe Fly
Specialised Therapeutics announces TGA approval of YORVIPATH
1M ago
ASND
Buy Rating for Ascendis Pharma: Yorvipath’s Strong Market Position and Growth Prospects
PremiumRatingsBuy Rating for Ascendis Pharma: Yorvipath’s Strong Market Position and Growth Prospects
1M ago
ASND
Ascendis Pharma: Favorable Market Position and Strong Prescription Growth Justify Buy Rating
Premium
Ratings
Ascendis Pharma: Favorable Market Position and Strong Prescription Growth Justify Buy Rating
1M ago
ASND
Ascendis Pharma price target raised to $180 from $175 at Morgan Stanley
Premium
The Fly
Ascendis Pharma price target raised to $180 from $175 at Morgan Stanley
1M ago
ASND
Ascendis Pharma’s Yorvipath: Impressive Launch and Strong Growth Potential Drive Buy Rating
PremiumRatings
Ascendis Pharma’s Yorvipath: Impressive Launch and Strong Growth Potential Drive Buy Rating
1M ago
ASND
Potential Share Dilution Looms for Ascendis Pharma: What Investors Need to Know
PremiumCompany Announcements
Potential Share Dilution Looms for Ascendis Pharma: What Investors Need to Know
1M ago
ASND
Ascendis Pharma A/S Earnings Call Highlights Growth and Challenges
PremiumCompany Announcements
Ascendis Pharma A/S Earnings Call Highlights Growth and Challenges
1M ago
ASND
Ascendis Pharma price target raised to $162 from $153 at TD Cowen
PremiumThe Fly
Ascendis Pharma price target raised to $162 from $153 at TD Cowen
1M ago
ASND
Ascendis Pharma price target lowered to $192 from $203 at BofA
PremiumThe FlyAscendis Pharma price target lowered to $192 from $203 at BofA
1M ago
ASND
Strong Buy Recommendation for Ascendis Pharma Driven by Yorvipath’s Successful US Launch and Future Growth Potential
Premium
Ratings
Strong Buy Recommendation for Ascendis Pharma Driven by Yorvipath’s Successful US Launch and Future Growth Potential
1M ago
ASND
Ascendis Pharma: Promising Developments and Growth Prospects Drive Buy Rating
Premium
Ratings
Ascendis Pharma: Promising Developments and Growth Prospects Drive Buy Rating
1M ago
ASND

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >